Maxcyte Inc (MXCT)

EBITDA Growth

23.10%

TTM · Period ending:

MXCT logo

MXCT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported23.10%
MXCT TTM EBITDA YoY % (43.58% → 23.10%)
High-resolution chart · PNG

MXCT ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Maxcyte Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
23.1042%
8.3143%
-7.4796%
-29.7775%
-18.7196%
-6.7558%
-0.7873%
13.2202%
-16.4992%
-28.4763%
-74.7356%
-68.6313%
-63.0042%
-92.2899%
-25.5691%
-50.485%
-20.3703%
-6.6245%
-66.3609%
-50.8198%
-74.6839%
-29.792%
15.4144%
22.1519%
32.1713%
0.4887%
-46.1038%
-37.7402%
-30.6553%
-9.9336%
11.6726%
-19.1295%
-69.0766%
-126.2564%
-249.4977%
-305.5051%
-447.8734%
-386.5516%
-291.9886%
-140.3308%
-21.1672%
16.5224%
43.5837%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.